查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631493

疫苗佐剂市场规模、份额、趋势分析报告：按类型、给药方法、应用、地区、细分预测，2025-2030 年

Vaccine Adjuvants Market Size, Share & Trends Analysis Report By Type (Pathogen, Adjuvant Emulsion, Particulate), By Administration (Oral, Intradermal, Intranasal, Intramuscular), By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

疫苗佐剂市场的成长与趋势

根据Grand View Research, Inc.的新报告，到2030年全球疫苗佐剂市场规模预计将达到48.6亿美元。预计 2025 年至 2030 年间，市场复合年增长率为 4.32%。由于创新疫苗抗原的免疫抗原性较差，佐剂研究在疫苗研发中逐渐显得重要。此外，人们越来越关注提供对现有和新出现的疾病的持久免疫力，预计将推动对疫苗佐剂的需求。

此外，子宫颈癌发生率的上升预计将促进市场的发展。根据 NCBI 统计，每年约有 15,000 名女性死于子宫颈癌。其他公司正在开发能够长期增强免疫反应的佐剂，例如 GSK 的 AS04 佐剂（用于人类乳突病毒疫苗）。

疫苗佐剂市场报告重点

  • 疫苗佐剂市场根据类型分为佐剂乳液、病原体、颗粒物、组合药物和其他。 2024 年，粒状物市场占有率。
  • 感染疾病部门在 2024 年占据最大的收益占有率，占 68.0%。这一巨大比例是由于疟疾、流感、甲型肝炎、乙型肝炎和丙型肝炎等感染疾病的流行逐渐增加。
  • 给药方式分为口服、皮内、鼻内、肌肉注射和其他。由于更好的免疫特异性，肌肉注射部分预计将在 2024 年占据最大的收益占有率，为 33.8%。
  • 北美将主导市场，到 2024 年将占据最大的收益占有率，达到 39.4%。成长要素对新疗法研发的投入增加以及致命传染病的增加。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章疫苗佐剂市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 渗透和成长前景规划
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 疫苗佐剂市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析

第 4 章 疫苗佐剂：类型、估计与趋势分析

  • 疫苗佐剂市场：关键要点
  • 疫苗佐剂市场：2024 年和 2030 年趋势和市场占有率分析
  • 病原体
    • 2018 年至 2030 年病原体市场估计与预测
  • 佐剂乳液
    • 2018 年至 2030 年佐剂乳液市场估计与预测
  • 微粒
    • 2018 年至 2030 年细颗粒市场估计与预测
  • 组合
    • 2018 年至 2030 年综合市场估计与预测
  • 其他的
    • 2018 年至 2030 年其他市场估计与预测

第 5 章 疫苗佐剂：依用途估计与趋势分析

  • 疫苗佐剂市场：关键要点
  • 疫苗佐剂市场：2024 年和 2030 年趋势和市场占有率分析
  • 感染疾病
    • 2018 年至 2030 年感染疾病市场估计与预测
  • 癌症
    • 2018 年至 2030 年癌症市场估计与预测
  • 其他的
    • 2018 年至 2030 年其他市场估计与预测

第 6 章 疫苗佐剂：按给药方法分類的估计和趋势

  • 疫苗佐剂市场：关键要点
  • 疫苗佐剂市场：2024 年和 2030 年趋势和市场占有率分析
  • 口服
    • 2018 年至 2030 年口腔市场估计与预测
  • 皮内
    • 2018 年至 2030 年皮内注射市场估计与预测
  • 鼻内
    • 2018 年至 2030 年鼻腔给药市场估计与预测
  • 肌肉注射
    • 2018 年至 2030 年肌肉注射市场估计与预测
  • 其他的
    • 2018 年至 2030 年其他市场估计与预测

第 7 章疫苗佐剂市场：区域、估计与趋势分析

  • 区域展望
  • 疫苗佐剂市场（按地区）: 关键要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的近期趋势及影响分析
  • 市场参与企业分类
    • GSK
    • Novartis/CSL
    • Agenus
    • Adjuvance
    • Novavax
    • SPI Pharma
    • Invivogen
    • Avanti Polar Lipids
    • Brentagg
Product Code: GVR-1-68038-612-7

Vaccine Adjuvants Market Growth & Trends:

The global vaccine adjuvants market is expected to reach USD 4.86 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 4.32% from 2025 to 2030. The significance of adjuvant research in the development of vaccines has increased gradually due to inadequate immunogenicity of innovative vaccine antigens. In addition, the growing focus on long-lasting immunization effect against existing and emerging diseases is expected to boost the demand for vaccine adjuvants.

Furthermore, rising prevalence of cervical cancer is anticipated to boost the market. According to NCBI, around 15,000 females die every year due to cervical cancer. There are certain companies developing vaccine adjuvants for this type of cancer in order to enhance the efficacy, such as AS04 adjuvant-adsorbed (human papillomavirus vaccine) by GSK, which boosts the immune response for a longer duration.

Vaccine Adjuvants Market Report Highlights:

  • The vaccine adjuvants market is segmented based on type into an adjuvant emulsion, pathogen, particulate, combination, and others. The particulate segment held the largest market share in 2024
  • The infectious diseases segment accounted for the largest revenue share of 68.0% in 2024. This large share can be attributed to the gradually growing prevalence of infectious diseases, such as malaria, influenza, hepatitis A, B, & C, and others.
  • The administration segment is categorized into oral, intradermal, intranasal, intramuscular, and others. Due to better immune specificity, the intramuscular segment accounted for the largest revenue share of 33.8% in 2024
  • North America dominated the market and accounted for the largest revenue share of 39.4% in 2024. The factors contributing to the growth of the market in the North American region are a rise in investments for R&D of new therapeutics and an increase in fatal epidemic diseases.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. Administration type
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. Administration outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Vaccine Adjuvants Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Vaccine Adjuvants Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Vaccine Adjuvants: Type Estimates & Trend Analysis

  • 4.1. Vaccine Adjuvants Market: Key Takeaways
  • 4.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2024 & 2030
  • 4.3. Pathogen
    • 4.3.1. Pathogen market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Adjuvant emulsion
    • 4.4.1. Adjuvant emulsion market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Particulate
    • 4.5.1. Particulate market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Combination
    • 4.6.1. Combination market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Vaccine Adjuvants: Application Estimates & Trend Analysis

  • 5.1. Vaccine Adjuvants Market: Key Takeaways
  • 5.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2024 & 2030
  • 5.3. Infectious diseases
    • 5.3.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Cancer
    • 5.4.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Vaccine Adjuvants: Administration Estimates & Trend Analysis

  • 6.1. Vaccine Adjuvants Market: Key Takeaways
  • 6.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2024 & 2030
  • 6.3. Oral
    • 6.3.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Intradermal
    • 6.4.1. Intradermal market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Intranasal
    • 6.5.1. Intranasal market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Intramuscular
    • 6.6.1. Intramuscular market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Vaccine Adjuvants Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Vaccine Adjuvants Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. GSK
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Novartis/CSL
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Agenus
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Adjuvance
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Novavax
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. SPI Pharma
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Invivogen
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Avanti Polar Lipids
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Brentagg
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America Vaccine Adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 5 North America vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 9 Canada vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 12 Mexico vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 13 Mexico vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 15 Europe vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 16 Europe vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 17 Europe vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 18 Europe vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
  • Table 19 Germany vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 20 Germany vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 22 UK vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 23 UK vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 25 France vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 26 France vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 27 France vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 28 Italy vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 29 Italy vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 31 Spain vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 32 Spain vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 34 Denmark vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 35 Denmark vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 37 Sweden vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 38 Sweden vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 40 Norway vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 41 Norway vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
  • Table 47 Japan vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 48 Japan vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 50 China vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 51 China vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 52 China vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 53 India vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 54 India vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 55 India vaccine adjuvants market, by administration, (USD Million) 2018 - 2030
  • Table 56 Australia vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 57 Australia vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 58 Australia vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 59 Thailand vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 60 Thailand vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 61 Thailand vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 62 South Korea vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 63 South Korea vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 64 South Korea vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 65 Latin America vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 66 Latin America vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 68 Latin America vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
  • Table 69 Brazil vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 70 Brazil vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 71 Brazil vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 72 Argentina vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 85 UAE vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
  • Table 88 Kuwait vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Vaccine adjuvants: Market outlook
  • Fig. 8 Vaccine adjuvants: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Vaccine adjuvants market driver impact
  • Fig. 14 Vaccine adjuvants market restraint impact
  • Fig. 15 Vaccine adjuvants market strategic initiatives analysis
  • Fig. 16 Vaccine adjuvants market: Type movement analysis
  • Fig. 17 Vaccine adjuvants market: Type outlook and key takeaways
  • Fig. 18 Pathogen market estimates and forecasts, 2018 - 2030
  • Fig. 19 Adjuvant emulsion market estimates and forecasts, 2018 - 2030
  • Fig. 20 Particulate market estimates and forecasts, 2018 - 2030
  • Fig. 21 Combination market estimates and forecasts, 2018 - 2030
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030
  • Fig. 23 Vaccine adjuvants market: Application movement analysis
  • Fig. 24 Vaccine adjuvants market: Application outlook and key takeaways
  • Fig. 25 Infectious diseases market estimates and forecasts, 2018 - 2030
  • Fig. 26 Cancer market estimates and forecasts, 2018 - 2030
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030
  • Fig. 28 Vaccine adjuvants market: Administration movement analysis
  • Fig. 29 Vaccine adjuvants market: Administration outlook and key takeaways
  • Fig. 30 Oral market estimates and forecasts, 2018 - 2030
  • Fig. 31 Intradermal market estimates and forecasts, 2018 - 2030
  • Fig. 32 Intranasal market estimates and forecasts, 2018 - 2030
  • Fig. 33 Intramuscular market estimates and forecasts, 2018 - 203
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030
  • Fig. 35 Global vaccine adjuvants market: Regional movement analysis
  • Fig. 36 Global vaccine adjuvants market: Regional outlook and key takeaways
  • Fig. 37 North America market estimates and forecasts, 2018 - 2030
  • Fig. 38 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 39 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 40 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 41 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 44 France market estimates and forecasts, 2018 - 2030
  • Fig. 45 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 47 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 48 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 49 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 50 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 51 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 52 China market estimates and forecasts, 2018 - 2030
  • Fig. 53 India market estimates and forecasts, 2018 - 2030
  • Fig. 54 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 55 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 56 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 57 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 58 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 59 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 60 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 61 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 63 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 64 Kuwait market estimates and forecasts, 2018 - 2030